Touyun Biotech Group Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported net loss was HKD 88.07 million compared to HKD 61.37 million a year ago. Basic loss per share from continuing operations was HKD 0.0314 compared to HKD 0.022 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 HKD | 0.00% | 0.00% | 0.00% |
Apr. 30 | China Touyun Tech Widens Loss in 2023 Amid Lower Sales Orders | MT |
Mar. 28 | Touyun Biotech Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 82.62M | |
+9.59% | 17.85B | |
-10.47% | 9.84B | |
+19.47% | 9.34B | |
-3.70% | 5.12B | |
+2.28% | 4.94B | |
-4.10% | 2.99B | |
+12.13% | 2.98B | |
-1.02% | 2.43B | |
+6.65% | 2.07B |
- Stock Market
- Equities
- 1332 Stock
- News Touyun Biotech Group Limited
- Touyun Biotech Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022